Literature DB >> 24755394

Environmental neurotoxins β-N-methylamino-l-alanine (BMAA) and mercury in shark cartilage dietary supplements.

Kiyo Mondo1, W Broc Glover2, Susan J Murch3, Guangliang Liu4, Yong Cai5, David A Davis6, Deborah C Mash7.   

Abstract

Shark cartilage products are marketed as dietary supplements with claimed health benefits for animal and human use. Shark fin and cartilage products sold as extracts, dry powders and in capsules are marketed based on traditional Chinese medicine claims that it nourishes the blood, enhances appetite, and energizes multiple internal organs. Shark cartilage contains a mixture of chondroitin and glucosamine, a popular nutritional supplement ingested to improve cartilage function. Sharks are long-lived apex predators, that bioaccumulate environmental marine toxins and methylmercury from dietary exposures. We recently reported detection of the cyanobacterial toxin β-N-methylamino-l-alanine (BMAA) in the fins of seven different species of sharks from South Florida coastal waters. Since BMAA has been linked to degenerative brain diseases, the consumption of shark products may pose a human risk for BMAA exposures. In this report, we tested sixteen commercial shark cartilage supplements for BMAA by high performance liquid chromatography (HPLC-FD) with fluorescence detection and ultra performance liquid chromatography/mass spectrometry/mass spectrometry (UPLC-MS/MS). Total mercury (Hg) levels were measured in the same shark cartilage products by cold vapor atomic fluorescence spectrometry (CVAFS). We report here that BMAA was detected in fifteen out of sixteen products with concentrations ranging from 86 to 265μg/g (dry weight). All of the shark fin products contained low concentrations of Hg. While Hg contamination is a known risk, the results of the present study demonstrate that shark cartilage products also may contain the neurotoxin BMAA. Although the neurotoxic potential of dietary exposure to BMAA is currently unknown, the results demonstrate that shark cartilage products may contain two environmental neurotoxins that have synergistic toxicities.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cyanotoxin; Dietary supplements; Mercury; Shark cartilage; β-N-methylamino-l-alanine

Mesh:

Substances:

Year:  2014        PMID: 24755394     DOI: 10.1016/j.fct.2014.04.015

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  20 in total

Review 1.  A critical review of the postulated role of the non-essential amino acid, β-N-methylamino-L-alanine, in neurodegenerative disease in humans.

Authors:  N Chernoff; D J Hill; D L Diggs; B D Faison; B M Francis; J R Lang; M M Larue; T-T Le; K A Loftin; J N Lugo; J E Schmid; W M Winnik
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2017-06-09       Impact factor: 6.393

2.  N-β-Methylamino-L-Alanine and Its Naturally Occurring Isomers in Cyanobacterial Blooms in Lake Winnipeg.

Authors:  Stephanie L Bishop; Jeff K Kerkovius; Frederic Menard; Susan J Murch
Journal:  Neurotox Res       Date:  2017-09-30       Impact factor: 3.911

3.  The Evaluation of BMAA Inhalation as a Potential Exposure Route Using a rat Model.

Authors:  Laura Louise Scott; Simoné Downing; Timothy Grant Downing
Journal:  Neurotox Res       Date:  2017-05-03       Impact factor: 3.911

Review 4.  Cyanobacterial Neurotoxins: Their Occurrence and Mechanisms of Toxicity.

Authors:  Kenneth J Rodgers; Brendan J Main; Kate Samardzic
Journal:  Neurotox Res       Date:  2017-06-05       Impact factor: 3.911

Review 5.  BMAA and Neurodegenerative Illness.

Authors:  Paul Alan Cox; Richard M Kostrzewa; Gilles J Guillemin
Journal:  Neurotox Res       Date:  2017-05-24       Impact factor: 3.911

6.  Assessing Environmental Exposure to β-N-Methylamino-L-Alanine (BMAA) in Complex Sample Matrices: a Comparison of the Three Most Popular LC-MS/MS Methods.

Authors:  Teesha C Baker; Fiona J M Tymm; Susan J Murch
Journal:  Neurotox Res       Date:  2017-06-22       Impact factor: 3.911

7.  BMAA extraction of cyanobacteria samples: which method to choose?

Authors:  Sandra Lage; Alfred Burian; Ulla Rasmussen; Pedro Reis Costa; Heléne Annadotter; Anna Godhe; Sara Rydberg
Journal:  Environ Sci Pollut Res Int       Date:  2015-08-26       Impact factor: 4.223

8.  Is Exposure to BMAA a Risk Factor for Neurodegenerative Diseases? A Response to a Critical Review of the BMAA Hypothesis.

Authors:  Dunlop Ra; Banack Sa; Bishop Sl; Metcalf Js; Murch Sj; Davis DA; Stommel Ew; Karlsson O; Brittebo Eb; Chatziefthimiou Ad; Tan Vx; Guillemin Gg; Cox Pa; Mash Dc; Bradley Wg
Journal:  Neurotox Res       Date:  2021-02-06       Impact factor: 3.911

9.  Beta-N-methylamino-L-alanine: LC-MS/MS optimization, screening of cyanobacterial strains and occurrence in shellfish from Thau, a French Mediterranean lagoon.

Authors:  Damien Réveillon; Eric Abadie; Véronique Séchet; Luc Brient; Véronique Savar; Michèle Bardouil; Philipp Hess; Zouher Amzil
Journal:  Mar Drugs       Date:  2014-11-17       Impact factor: 5.118

10.  New Typical Vector of Neurotoxin β-N-Methylamino-l-Alanine (BMAA) in the Marine Benthic Ecosystem.

Authors:  Aifeng Li; Jialiang Song; Yang Hu; Longji Deng; Ling Ding; Meihui Li
Journal:  Mar Drugs       Date:  2016-11-04       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.